Mink Net Tangible Assets from 2010 to 2024
| INKT Stock | USD 0.96 0.03 3.03% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter -461.5 K | Current Value -484.6 K | Quarterly Volatility 21.2 M |
Check Mink Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 584.4 K, Depreciation And Amortization of 256.1 K or Interest Expense of 216.6 K, as well as many indicators such as Price To Sales Ratio of 0.0355, Dividend Yield of 0.0 or Days Sales Outstanding of 134. Mink financial statements analysis is a perfect complement when working with Mink Therapeutics Valuation or Volatility modules.
Mink | Net Tangible Assets |
Latest Mink Therapeutics' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Mink Therapeutics over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Mink Therapeutics' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mink Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Mink Net Tangible Assets Regression Statistics
| Arithmetic Mean | (26,318,845) | |
| Geometric Mean | 15,051,352 | |
| Coefficient Of Variation | (80.47) | |
| Mean Deviation | 17,027,264 | |
| Median | (36,333,760) | |
| Standard Deviation | 21,178,751 | |
| Sample Variance | 448.5T | |
| Range | 77.7M | |
| R-Value | 0.63 | |
| Mean Square Error | 292.1T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | 2,977,357 | |
| Total Sum of Squares | 6279.6T |
Mink Net Tangible Assets History
About Mink Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Mink Therapeutics income statement, its balance sheet, and the statement of cash flows. Mink Therapeutics investors use historical funamental indicators, such as Mink Therapeutics's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Mink Therapeutics investors may use each financial statement separately, they are all related. The changes in Mink Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mink Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mink Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mink Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | -461.5 K | -484.6 K |
Pair Trading with Mink Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mink Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Mink Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mink Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mink Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mink Therapeutics to buy it.
The correlation of Mink Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mink Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mink Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mink Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.